Loading...
XSHG
600789
Market cap1.27bUSD
Oct 09, Last price  
8.28CNY
1D
1.60%
1Q
19.48%
Jan 2017
10.84%
Name

Shandong Lukang Pharmaceutical Co Ltd

Chart & performance

D1W1MN
XSHG:600789 chart
P/E
77.06
P/S
1.50
EPS
0.11
Div yield, %
1.37%
Shrs. gr., 5y
0.53%
Rev. gr., 5y
6.52%
Revenues
5.77b
-7.49%
1,113,640,0001,400,389,0001,731,856,0001,945,165,0002,196,145,0002,332,873,0002,339,454,2612,210,685,3422,312,103,1372,410,287,7152,505,591,8942,599,288,8803,329,604,7873,732,718,8824,205,109,0964,923,783,8705,621,441,9026,146,721,4386,233,090,1675,766,115,536
Net income
112m
-71.54%
-96,538,00025,974,00035,205,00037,580,000129,611,00015,013,000-133,834,24410,857,948-125,214,5277,897,23429,102,008114,236,713161,386,665121,251,314227,876,52289,098,699138,013,134246,171,799394,615,736112,304,823
CFO
698m
+73.32%
56,244,000137,296,000209,387,000199,492,000308,883,000123,285,000115,202,000256,497,000108,564,00078,386,000296,232,000275,510,000351,086,000361,867,000234,552,000177,492,024444,377,000604,006,000402,818,000698,173,849
Dividend
Jul 15, 20260.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shandong Lukang Pharmaceutical Co.,Ltd., a Chinese enterprise, primarily focuses on the production and distribution of bio-pharmaceuticals and antibiotics. Their comprehensive product range features active pharmaceutical ingredients (APIs) and finished drug formulations for both human and veterinary use, alongside bio-pesticides, traditional herbal remedies, and amino acids. Beyond its core pharmaceutical operations, the company also engages in environmental management services, including wastewater treatment, odor control, and the maintenance of sewage facilities, as well as the manufacturing and sale of ecological protection materials. Established in 1966 as Jining Antibiotic Factory, the firm rebranded to its current name in October 1993. Headquartered in Jining, China, it maintains a global footprint, distributing its offerings to approximately 40 nations across Asia, Europe, Africa, and the United States.

Key people

Jing Zhang
Finance Director, Director · since 2024
Haifeng Cao
Deputy General Manager · since 2020
Defeng He
Deputy General Manager · since 2020
Zhigang Jin
Deputy General Manager · since 2024
Sujuan Yang
Deputy General Manager · since 2024
Baokun Jing
Secretary of the Board · since 2024
Kun Dong
General Manager, Director · since 2021
Chengtong Liu
Director · since 2024
Xin Peng
Chairman of the Board · since 2024
Director · since 2022
Wei Zhao
Director · since 2024
Zixin Deng
Independent Director · since 2021
Liliang Feng
Independent Director · since 2021
Independent Director · since 2021
IPO date
Feb 26, 1997
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
山东省济宁高新区德源路88号
济宁市, SD 250000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT